ERIN RISCO: Open Payments
NPI 1295172989 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,750 in 100 payments from 20 companies in 2025. Trend: 2023 $2,720 · 2024 $2,784 · 2025 $1,750
Food & beverage: $1,750
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $387 |
| Novartis Pharmaceuticals Corporation | 20 | $306 |
| Incyte Corporation | 11 | $185 |
| Organon LLC | 4 | $153 |
| Lilly USA, LLC | 6 | $138 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $87 |
| Regeneron Healthcare Solutions, Inc. | 4 | $84 |
| UCB, Inc. | 4 | $73 |
| PFIZER INC. | 3 | $55 |
| Arcutis Biotherapeutics, Inc. | 3 | $50 |
Products named: RINVOQ, COSENTYX, OPZELURA, SKYRIZI, VTAMA, EBGLYSS, DUPIXENT, Bimzelx.
Industry payments across AL — which companies pay providers there.
